Trials / Completed
CompletedNCT05874232
The Impact of Heartfulness Self-Care Program on Anxiety, Satisfaction With Life, and Loneliness Levels in Students and Staff in High Schools.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 203 (actual)
- Sponsor
- Heartfulness Institute · Academic / Other
- Sex
- All
- Age
- 14 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This quantitative study assesses the baseline anxiety, satisfaction with life, and loneliness scores in students and staff in a global study. Assessments at baseline will include the GAD, SWLS, and UCLA loneliness scale, and the same questionnaires were collected in Week 4 and Week 8. The Google form questionnaire will ask the high schoolers and staff for their email address and their parent's email address (if they are under 18). The form will also include a question eliciting interest in participation in the 4-weeks Heartfulness program. The program will include tools that promote a heart-based nurturing environment focusing on relaxation, positivity, and developing growth mindsets.
Detailed description
The specific aim of this study is to assess changes in scores measuring symptoms of anxiety using GAD-7 (and GAD-Child), Satisfaction with Life Scale (SWLS and SWLS-C), and UCLA Loneliness Scale (Version 3).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Self-Care Program through Heartfulness | A four-week Self-Care program through Heartfulness will be offered to participants in the Heartfulness group. This would include a daily practice of relaxation tools for 15 minutes a day using an app and once a weekly webinar for 30 minutes. Guided relaxation and meditation sessions will be offered to the participants during the intervention weeks. These virtual sessions were conducted by Heartfulness Champions and certified trainers from Heartfulness Institute. |
Timeline
- Start date
- 2022-02-03
- Primary completion
- 2022-06-03
- Completion
- 2022-07-03
- First posted
- 2023-05-24
- Last updated
- 2023-05-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05874232. Inclusion in this directory is not an endorsement.